Alzheimers Disease Completed Phase 4 Trials for Florbetapir (18F) (DB09149)

IndicationStatusPhase
DBCOND0036596 (Alzheimers Disease)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01946243The Feasibility of Florbetapir QuantitationDiagnostic